Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Bassem Hassan joins Paris Brain Institute

Published on: 29/01/2016 Reading time: 1 min
bassem hassan
Retour à la recherche

Paris Brain Institute brings together in one place patients, doctors and researchers in order to rapidly develop treatments for nerve damage and apply these to patients as soon as possible. Coming from all backgrounds and countries, the best scientists work on the most advanced research in the field. In 2013, an international call for tender was launched to welcome new teams. In this context, Bassem Hassan, a world-renowned neuroscientist, joined the Institut du Cerveau - ICM alongside the 25 existing research teams.

BASSEM HASSAN, SCIENTIFIC EXCELLENCE FOR PATIENT CARE

The Bassem Hassan team focuses on the genetic mechanisms that control early development of the nervous system, cell specification in the formation of neural circuits, as well as the mechanisms involved in neurological diseases, by using Drosophila as a model.

Bassem Hassan team focuses on three main areas of study:

  • The relationship between the individual specificity of a brain network and his/her behaviour
  • The molecular mechanisms responsible for the differentiation of neural stem cells
  • The study of the mechanisms in some diseases:
    • Alzheimer’s disease, by investigating whether the modulation of Wnt signaling pathway by the precursor of amyloid peptide plays a role in the pathology
    • The fragile-X syndrome, studying whether the fragile-X protein plays a role in brain organisation

ABOUT BASSEM HASSAN

Bassem Hassan joined Paris Brain Institute in January 2016 where he is now head of the “Brain Development” team. Once obtained his PhD in molecular genetics at Ohio University in 1996, he completed his post-doctorate at Baylor College of Medicine in Houston, Texas. From 2001 to 2015, he was senior group leader at “VIB Center for the Biology of Disease” and Professor at the “Center for Human Genetics” at the University of Leuven in Belgium. In 2003, he was awarded the EMBO “Young Investigator” and in 2009 he was elected EMBO member. In 2015, he was named “Einstein Visiting Fellow” for 2016-2018 years at the Free University of Berlin and NeuroCure cluster.

A CALL FOR TENDERS REVEALING THE STRONG ATTRACTIVENESS OF THE Institut du Cerveau - ICM

A call for tenders was launched in spring 2013 to welcome new teams. The Institute received 83 application forms, 90% of international candidates. The interviews were conducted in February 2014. 11 shortlisted candidates were heard by the International Scientific Council of the Institute. A final selection was made late 2014 / early 2015.

Bassem Hassan was ranked first within the international “new teams” call.

With his work, Bassem Hassan, alongside 650 researchers, engineers and technicians of the Institute, will contribute to major progress for nervous system diseases.

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news